HKU iCube Annual Gala Luncheon 2025 - Talent Management in the Age of AI
Keynote Speakers (Group Photo) - From left to right: Prof. Hongbin CAI, Dean of HKU Business School, The University of Hong Kong; Ms. Clara CHAN, Chief Executive Officer, Hong Kong Investment Corporation Limited; Ir. Tony WONG, JP, Commissioner for Digital Policy, Hong Kong Special Administrative Region Government; Prof. Jin LI, Director of HKU's Centre for AI, Management and Organization (CAMO), HKU Business School
The gala brought together a distinguished lineup of speakers from government, academia, and the business community, alongside 60 esteemed delegates, including industry leaders, talent management experts, and innovators. Together, they shared actionable insights in leveraging AI to drive workforce transformation, foster innovation, and ensure organizational success in a digital era.
Highlights from the Event
In his opening speech, Professor Hongbin Cai, Dean of HKU Business School, reaffirmed the School's commitment to being a global leader in business education. He emphasized HKUBS's mission to nurture future-ready business leaders equipped to excel in an AI-driven world. Professor Cai also announced an exciting new initiative: the launch of a Taught Postgraduate stream in AI and Business, designed to equip students with cutting-edge AI knowledge and its practical applications in business.
Ms. Clara Chan, Chief Executive Officer of Hong Kong Investment Corporation Limited (HKIC), spoke about 'opportunities and challenges in high-tech investment for Hong Kong's future.' She emphasized that strategic investments in AI and technological innovation are key to maintaining and enhancing Hong Kong's competitive edge on the global stage. She also covered the HKIC's role in accelerating the nurturing of new quality productive forces, facilitating investee companies regarding product and service innovation as well as productivity improvement, and conducting more comprehensive talent development.
Ir. Tony Wong, JP, Commissioner for Digital Policy, delivered a keynote addressed on 'AI Ecosystem Development'. He highlighted the Government's effort on promoting ethical development of AI and R&D of AI in Hong Kong, fostering an AI-savvy workforce, provided an overview of the support offered to the industry, and shared insights on promoting AI applications and training within the Government.
Professor Jin Li, Zhang Yonghong Professor of Economics and Strategy at HKU Business School, introduced the University's groundbreaking initiative: the establishment of the Centre for AI, Management and Organization (CAMO). As the founding Director of CAMO, Professor Li outlined the Centre's mission: 'The Centre is envisioned as a leading hub for interdisciplinary AI research and collaboration in the business sector. By bringing together experts from both industry and academia, CAMO aims to advance the development and applications of artificial intelligence to solve real-world challenges in management and organizational strategy.'
A Platform for Innovation and Collaboration
The HKU iCube Gala Luncheon was a tremendous success, fostering cross-sector collaboration and serving as a dynamic platform for thought leadership and innovation. The event showcased HKU iCube's commitment to advancing youth development and driving impactful change by connecting academics, industry leaders, and policymakers.
As the Friends of iCube Network continues to grow, HKU iCube remains dedicated to facilitating meaningful conversations and partnerships that create shared value and inspire solutions for a better future.
For more information about HKU iCube and upcoming events, visit www.hku-icube.hku.hk
Hashtag: #HKUiCube #HKU
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?
Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The rally has been powered by cooling inflation, resilient earnings, and fading tariff concerns after April's policy shock. Just three months back, the market briefly dipped toward bear territory amid geopolitical tensions, China's AI push, tariff fears, and fiscal uncertainty, keeping investors on edge about the rebound's staying power. Despite the S&P rallying over 28% from its April lows of $4,835, the bull run has still left many big names behind. Nearly a third of the index's stocks still ended the first half of 2025 in the red. UnitedHealth (UNH), a giant in health insurance and managed care services, has plunged 39% so far in 2025. UNH stock has been hit by soaring Medicare Advantage costs, a probe into Medicare fraud, and a sudden CEO exit, making it the index's fourth-worst performer. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Is Super Micro Computer Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! While UNH is at five-year lows, a 1.8% five-day bounce hints at some life. With the dividend-paying stock halved and trading at a compelling valuation, is this a classic 'buy the dip' setup? Or a moment for caution despite the allure of value and yield? Founded in 1977, UnitedHealth has grown into a $295 billion healthcare heavyweight. With its deep roots in health insurance and care services, the company runs on two powerhouse engines: UnitedHealthcare and Optum. UnitedHealthcare handles the insurance side, offering plans that serve over 50 million people. It's the backbone, giving the company scale, reach, and reliable revenue. But it's Optum that brings the spark, driving growth through data, tech, and pharmacy solutions. From analytics to care delivery, Optum's strategy pushes innovation across the system. Together, these segments give the company its edge in a complex healthcare landscape. UNH stock has been in free fall in 2025, hitting a low of $248.88 in May. Over the past 52 weeks, the stock has declined 38%, trailing far behind the broader S&P's surge of 13%. However, UNH stock is rebounding, up 1% over the past month. UnitedHealth's downfall in 2025 was not just a single bad headline. It was a chain reaction that started fast and spiraled hard. It kicked off on April 17, when the company shocked the Street by slashing its full-year earnings forecast. This was because a flood of higher-acuity Medicare Advantage patients drove costs far beyond expectations, exposing just how outdated and fragile their forecasting models had become. Then May hit like a wrecking ball. CEO Andrew Witty abruptly resigned, raising eyebrows amid growing pressure. Days later, reports surfaced of a U.S. Department of Justice investigation into alleged Medicare fraud. By mid-May, the stock had crashed, hitting five-year lows. Just when it seemed the damage was done, more scandal dropped with accusations of UnitedHealth secretly paying nursing homes to avoid costly hospital transfers. Even insider buying gave only a brief lift to UNH. In a short span, UnitedHealth went from a rock-solid name to a cautionary tale unraveling in real time. After its brutal springtime plunge, UNH stock is priced at 14 times forward earnings and 0.7 times sales, trading in bargain territory. Those multiples sit well below both the sector medians and its own five-year averages, catching the eye of value hunters sniffing out a possible rebound. Despite the stock's decline, UnitedHealth has signaled some confidence where it counts: dividends. In June, the company hiked its quarterly payout by 5.2% to $2.21, marking 15 consecutive years of increases. Paid out on June 24, the hike pushed its annual yield near 2.6%. On April 17, UnitedHealth reported Q1 2025 earnings, and it wasn't the kind of update Wall Street wanted to hear. Revenue climbed 9.8% year-over-year (YOY) to $109.6 billion but still came in shy of expectations. Adjusted EPS rose 4.2% to $7.20 yet missed the estimated mark of $7.27. UnitedHealthcare, the insurance arm, posted a solid 12.2% revenue gain to $84.6 billion. Meanwhile, Optum saw more modest growth of 4.6% to $63.9 billion, with Optum Rx doing the heavy lifting. Still, rising costs loomed large. Total operating expenses surged 9.4% annually to $100.5 billion. On the brighter side, the company exited the quarter with $34.3 billion in cash and short-term investments and generated $5.5 billion in operating cash flow. Shareholders weren't left in the cold either, with over $5 billion returned through buybacks and dividends. UnitedHealth's steep selloff wasn't just about Q1 results. It was the guidance cut that really rattled sentiment. Management slashed its 2025 adjusted EPS outlook to between $26 and $26.50, down from the initially forecast range of $29.50 to $30 in December 2024 and below fiscal 2024 adjusted EPS of $27.66. Surging Medicare Advantage costs and shifts in Optum's patient mix have taken a real bite. Now, all eyes are on the fiscal Q2 report, expected to be released on July 29 before the market opens. Analysts forecast the Q2 bottom line to be around $5.08 per share, down 25% YOY. Looking to fiscal 2025, adjusted EPS is expected to decline 20% annually to $22.07, then surge by 15% to $25.39 in fiscal 2026. Last Wednesday, UBS reiterated its 'Buy' rating on UNH stock but trimmed the price target to $385 from $400. The cut followed CEO Stephen Hemsley's cautious tone at the June 2 meeting, hinting at more conservative 2025 guidance. UBS anticipates fiscal 2025 EPS closer to $20, down from the earlier $22.50 consensus. Margins were also revised, with Medicare Advantage trimmed to 1.5% and Optum Health lowered to 4.5%. Despite the recent shakeups, Wall Street hasn't completely hit the panic button yet. Last month, UnitedHealth shook things up by axing broker commissions on select Medicare Advantage plans — a move aimed at trimming the cost that forced it to yank full-year guidance. Hightower Chief Investment Strategist Stephanie Link called it a smart pivot, saying the same issue 'got them in trouble' to begin with. Link is bracing for short-term volatility but stays bullish long-term, calling UNH stock 'too cheap' for a top-tier name in the industry. There's still optimism in the air, but with a touch of caution. UNH stock has a 'Moderate Buy' consensus overall, down from a consensus 'Strong Buy' rating a month ago. Of the 24 analysts covering the stock, 15 advise a 'Strong Buy,' two suggest a 'Moderate Buy,' and seven analysts play it safe with a 'Hold.' The mean price target of $363.43 implies shares could rise as much as 18%. The Street-high target of $440, way below this year's highs, signals that UNH has an upside potential of 43% from current levels. The U.S. healthcare industry, despite constant political firestorms, is built to endure. For years, UnitedHealth has stood as its crown jewel. Defensive, dividend-paying, and shock-resistant, it has been the kind of stock long-term investors can count on. But 2025 has shattered that illusion. While the broader market climbs to record highs, UnitedHealth's dramatic plunge reminds us that even giants can stumble hard. Sure, UNH stock now trades at a discount, offering an attractive dividend yield. Insiders are buying shares, and UnitedHealth still commands significant market share and robust cash flow. But is this really a 'buy the dip' moment? It's probably a bet that management can steady the ship, and the storm eventually clears. Until then, UnitedHealth sits in a gray zone between legacy and uncertainty, where long-term promise collides with short-term pain. Investors should exercise caution before jumping in. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Stifel Reiterates Buy Rating on Host Hotels & Resorts (HST)
Host Hotels & Resorts, Inc. (NASDAQ:HST) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on HST with a price target of $15.47. The company's 7.11% dividend yield enhances its investment appeal. Analysts noted that the multifamily space delivered quarterly results that largely met anticipated benchmarks. Analysts flagged early signs of improvement in the downtown San Francisco, particularly the Downtown and Peninsula submarkets, historically among the slowest to recover since the pandemic. Analysts observed that multifamily transaction activity is rising, lending credibility to their positive outlook. The continued attention on the sector highlights ongoing interest in its recovery and performance trends. A high-end hotel lobby, with modern furnishings, lush carpeting, and natural light. Stifel's Buy recommendation on Host Hotels & Resorts, Inc. (NASDAQ:HST) indicates confidence in its growth trajectory, and the $15.47 price target implies room for higher valuation. Host Hotels & Resorts, Inc. (NASDAQ:HST) is one of the largest lodging-focused REITs, with a portfolio comprising luxury and upper-upscale properties across domestic and international markets. While we acknowledge the potential of HST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
17 minutes ago
- Forbes
Post-Transformer Model Systems Can Drive Change
Chipset on circuit board for semiconductor industry, 3d rendering What if you could have conventional large language model output with 10 times to 20 times less energy consumption? And what if you could put a powerful LLM right on your phone? It turns out there are new design concepts powering a new generation of AI platforms that will conserve energy and unlock all sorts of new and improved functionality, along with, importantly, capabilities for edge computing. What is Edge Computing? Edge computing occurs when the data processing and other workloads take place close to the point of origin, in other words, an endpoint, like a piece of data collection hardware, or a user's personal device. Another way to describe it is that edge computing starts to reverse us back away from the cloud era, where people realized that you could house data centrally. Yes, you can have these kinds of vendor services, to relieve clients of the need to handle on-premises systems, but then you have the costs of transfer, and, typically, less control. If you can simply run operations locally on a hardware device, that creates all kinds of efficiencies, including some related to energy consumption and fighting climate change. Enter the rise of new Liquid Foundation Models, which innovate from a traditional transformer-based LLM design, to something else. A September 2024 piece in VentureBeat by Carl Franzen covers some of the design that's relevant here. I'll include the usual disclaimer: I have been listed as a consultant with Liquid AI, and I know a lot of the people at the MIT CSAIL lab where this is being worked on. But don't take my word for it; check out what Franzen has to say. 'The new LFM models already boast superior performance to other transformer-based ones of comparable size such as Meta's Llama 3.1-8B and Microsoft's Phi-3.5 3.8B,' he writes. 'The models are engineered to be competitive not only on raw performance benchmarks but also in terms of operational efficiency, making them ideal for a variety of use cases, from enterprise-level applications specifically in the fields of financial services, biotechnology, and consumer electronics, to deployment on edge devices.' More from a Project Leader Then there's this interview at IIA this April with Will Knight and Ramin Hasani, of Liquid AI. Hasani talks about how the Liquid AI teams developed models using the brain of a worm: C elegans, to be exact. He talked about the use of these post-transformer models on devices, cars, drones, and planes, and applications to predictive finance and predictive healthcare. LFMs, he said, can do the job of a GPT, running locally on devices. 'They can hear, and they can talk,' he said. More New Things Since a recent project launch, Hasani said, Liquid AI has been having commercial discussions with big companies about how to apply this technology well to enterprise. 'People care about privacy, people care about secure applications of AI, and people care about low latency applications of AI,' he said. 'These are the three places where enterprise does not get the value from the other kinds of AI companies that are out there.' Talking about how an innovator should be a 'scientist at heart,' Hasani went over some of the basic value propositions of having an LLM running offline. Look, No Infrastructure One of the main points that came out of this particular conversation around LFMs is that if they're running off-line on a device, you don't need the extended infrastructure of connected systems. You don't need a data center or cloud services, or any of that. In essence, these systems can be low-cost, high-performance, and that's just one aspect of how people talk about applying a 'Moore's law' concept to AI. It means systems are getting cheaper, more versatile, and easier to manage – quickly. So keep an eye out for this kind of development as we see smarter AI emerging.
